DOCSLIB.ORG

International Journal of Pharmaceutics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International Journal of Pharmaceutics INTERNATIONAL JOURNAL OF PHARMACEUTICS AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 0378-5173 DESCRIPTION . The International Journal of Pharmaceutics has an open access mirror journal International Journal of Pharmaceutics: X which has the same aims and scope and peer-review process. To submit to International Journal of Pharmaceutics: X visit https://www.editorialmanager.com/IJPHARMX/default.aspx. The International Journal of Pharmaceutics is the second most cited journal in the "Pharmacy & Pharmacology" category out of 358 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues. Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher. Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles. AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ijpharm 1 AUDIENCE . Pharmaceutical Scientists, Clinical Pharmacologists, Chemical Engineers, Biotechnologists. IMPACT FACTOR . 2020: 5.875 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . PubMed/Medline CAB International Current Contents - Life Sciences and Clinical Medicine Elsevier BIOBASE International Pharmaceutical Abstracts BIOSIS Citation Index Chemical Abstracts Scopus Embase Pascal Francis Science Citation Index EDITORIAL BOARD . Editor-in-Chief Jürgen Siepmann, University of Lille Faculty of Pharmacy, 3 rue du Professeur Laguesse, 59006, Lille cedex, France Editors for North America Zhengrong Cui, The University of Texas at Austin Division of Molecular Pharmaceutics and Drug Delivery, 2409 University Ave., A1900, 78712-0120, Austin, Texas, United States of America for Japan and Far East Yongzhuo Huang, Shanghai Institute of Materia Medica Chinese Academy of Sciences, 199 Guo Shou Jing Rd.,, 201203, Shanghai, China Fumiyoshi Yamashita, Kyoto University Graduate School of Pharmaceutical Sciences, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, Japan Sung-Joo Hwang, Yonsei University College of Pharmacy, 85 Songdogwahak-ro, 21983, Incheon, Yeonsu-gu, South Korea for Rest of the World Carmen Alvarez-Lorenzo, Universidade de Santiago de Compostela Faculty of Pharmacy, School Of Pharmacy Campus Vida, 15782, Santiago de Compostela, Spain Abdul Basit, University College London School of Pharmacy, 29-39 Brunswick Square, WC1N 1AX, London, United Kingdom Leena Peltonen, University of Helsinki, 00014, Helsinki, Finland Adriana R. Pohlmann, Universidade Federal do Rio Grande do Sul Programa de Pós-Graduação em Ciências Farmacêuticas, PORTO ALEGRE, Brazil Raymond Schiffelers, University Medical Centre Utrecht Laboratory of Clinical Chemistry and Haematology, Heidelberglaan 100, 3584 CX, Utrecht, Netherlands for Reviews Juan M. Irache, University of Navarre Department of Technological Pharmacy and Pharmacy Chemistry, Irunlarrea, 1, E-31080, Pamplona, Spain Editorial Board Göran Alderborn, Uppsala University Faculty of Pharmacy, Uppsala, Sweden Eric Allémann, University of Geneva Faculty of Science, Geneva, Switzerland Maria Josè Alonso, Universidade de Santiago de Compostela Faculty of Pharmacy, Santiago de Compostela, Spain AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ijpharm 2 Karim Amighi, ULB Faculty of Pharmacy, Bruxelles, Belgium Oral, Parenteral, Lung and Nasal Drug Delivery, Drug Targeting, Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Lung Aspergillosis, Cancer, Monoclonal Antibodies, Nanobodies. David Attwood, The University of Manchester Division of Pharmacy and Optometry, Manchester, United Kingdom Patrick F. Augustijns, Katholieke Universiteit Leuven Farmacotechnologie en Biofarmacie, Leuven, Belgium Gillian Barratt, Paris-Saclay University Faculty of Pharmacy, Chatenay Malabry, France Ruggero Bettini, University of Parma Department of Biosciences, Parma, Italy Maria Blanco-Prieto, University of Navarra, Navarra, Spain Paolo Blasi, University of Bologna Department of Pharmacy and Biotechnology, Bologna, Italy Pharmaceutical nanotechnology, Brain drug delivery, Lung delivery, Cell encapsulation Roland Bodmeier, Free University of Berlin Faculty of Biology Chemistry Pharmacology, Berlin, Germany Ben J. Boyd, Monash University, Clayton, Victoria, Australia Hak-Kim Chan, The University of Sydney School of Pharmacy, Sydney, Australia Han-Gon Choi, Hanyang University Institute of Pharmaceutical Science and Technology, Ansan, South Korea Paolo Colombo, University of Parma Department of Pharmacy, Parma, Italy Duncan Craig, University College London School of Pharmacy, London, United Kingdom Daan Crommelin, Utrecht University Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands Drug Targeting, Liposomes, Controlled Release. Shyamal Chandra Das, University of Otago New Zealand's National School of Pharmacy, Dunedin, New Zealand Respiratory Drug Delivery, Dissolution, Surface Energy, Tuberculosis, Dry Powder Inhaler Giuseppe De Rosa, University of Naples Federico II, Via Cintia, Naples, Italy Dominique Duchêne, Paris-Saclay University Faculty of Pharmacy, Chatenay Malabry, France Julia Engert, Ludwig Maximilian University Munich Department of Pharmacy, Munchen, Germany Brigitte Evrard, University of Liege Department of Pharmaceutical Sciences, Liege, Belgium Anna Maria Fadda, University of Cagliari Department of Life Sciences and Environment, Cagliari, Italy Elias Fattal, Paris-Saclay University Faculty of Pharmacy, Chatenay Malabry, France Jim Ford, Liverpool John Moores University School of Pharmacy and Biomolecular Sciences, Liverpool, United Kingdom Simon Gaisford, University College London School of Pharmacy, London, United Kingdom Huile Gao, Sichuan University Key Laboratory of Drug Targeting and Drug Delivery System, Chengdu, China Drug delivery systems, nanoparticles, tumor microenvironment, brain targeting delivery Andrea Gazzaniga, University of Milan Department of Pharmaceutical Sciences, Milano, Italy Achim Goepferich, University of Regensburg Faculty of Chemistry and Pharmacy, Regensburg, Germany Richard H. Guy, University of Bath Department of Pharmacy and Pharmacology, Bath, United Kingdom Jonathan Hadgraft, University College London School of Pharmacy, London, United Kingdom Hideyoshi Harashima, Hokkaido University Faculty of Pharmaceutical Sciences, Sapporo, Japan Research Expertise: Gene delivery, nanomedicine, microfluidics, cancer immunology, mitochondria, BBB. Masahiro Hayashi, Tokyo University of Pharmacy and Life Science School of Pharmacy Department of Biopharmaceutics, Hachioji, Japan Paul W. S. Heng, National University of Singapore Department of Pharmacy, Singapore, Singapore Yogeshvar Kalia, University of Geneva School of Pharmaceutical Sciences, Geneva, Switzerland Topical &, , Transdermal Delivery, Ocular Delivery, Intestinal Absorption, Formulation, Polymeric micelles Mansoor Khan, Center for Drug Evaluation and Research Office of Medical Policy, Silver Spring, Maryland, United States of America Peter Kleinebudde, Heinrich Heine University Düsseldorf Institute of Pharmaceutics and Biopharmaceutics, Düsseldorf, Germany Gaetano Lamberti, University of Salerno Department of Industrial Engineering, Fisciano, Italy Majella E. Lane, University College London School of Pharmacy, London, United Kingdom Anette Larsson, Chalmers University of Technology Applied Chemistry, Gothenburg, Sweden Panos Macheras, National and Kapodistrian University of Athens Department of Pharmaceutical Technology, Athens, Greece Karsten Mäder, Martin Luther University Halle-Wittenberg Department of Pharmacy, Halle, Germany Biodegradable Polymers; In Vivo, Nanoparticles, Implants, Microparticles Ashim Mitra, University
Load more

Recommended publications
  • Pharmaceutics (PCEU) 1
    Pharmaceutics (PCEU) 1 PCEU 615. Applied Pharmacokinetics. 2.5 Hours. PHARMACEUTICS (PCEU) Semester course; 2.5 lecture hours. 2.5 credits. Extends the concepts of pharmacokinetics as applied to dosage regimen design, pharmacokinetic PCEU 501. Pharmaceutical Calculations. 1 Hour. variability, drug interactions and statistical strategies for individualization Semester course; 1 lecture hour. 1 credit. This course is designed in a of drug therapy. Lectures and conferences take place throughout the student-centered learning format that supports self-directed learning. The semester. course will help students develop the skill set needed to screen out the PCEU 621. Advanced Pharmaceutics and Drug Disposition. 3 Hours. distractors from the determinant variables in a statement problem and Semester course; 3 lecture hours. 3 credits. Study at the advanced guide their thought processes in sequential use of information to solve level of the relationships between the physiochemical properties of a calculation problems seen in pharmacy practice. drug and dosage form and the absorption, distribution, elimination and PCEU 507. Pharmaceutics and Biopharmaceutics I. 3 Hours. pharmacological effects of the drug. Current theory and methodology Semester course; 3 lecture hours. 3 credits. Designed to describe involved in solving problems at the research level are emphasized. the physico-chemical and biopharmaceutical principles fundamental PCEU 622. Clinical Pharmacokinetics. 3 Hours. to the development of pharmaceutical dosage forms. Topics will Semester course; 2 lecture and 2 laboratory hours. 3 credits. The include pharmaceutical calculations, solid-state properties, solubility, application of current pharmacokinetic theory to clinical problems partitioning, solution properties, disperse systems, micromeritics, involved in optimizing and monitoring drug use in patients.
    [Show full text]
  • Guidelines for Authors (Revised January 2010)
    Guidelines for Authors (Revised January 2010) Contents (click on the topic) Objectives – Articles – Brief Articles – Current Reviews – Communications | Editorial Organization | Preparation of Electronic Manuscripts | Assembly of Manuscripts – Author Checklist – Title Page – Table of Contents Graphic – Abstract – Keywords – Abbreviations – Introduction – Experimental Section – Results – Discussion – Acknowledgment – Supporting Information – References – Tables – Figure Captions – Illustrations: Figures, Schemes, etc. – Nomenclature – Software – Coordinate Deposition | Submission – Copyright | Publication – Proofs – “Just Accepted” Manuscripts – ASAP Publication – ACS Policies for E-prints and Reprints Objectives The purpose of Molecular Pharmaceutics is to publish the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part
    [Show full text]
  • (FMIPA) DAN TEKNIK KIMIA ( FTI) ACS E-Journals
    DAFTAR JURNAL INTERNASIONAL UNTUK : PROGRAM STUDI KIMIA (FMIPA) DAN TEKNIK KIMIA ( FTI) ACS E-Journals Publisher: American Chemical Society ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 Number of title: 55 journals Subject : Chemical : Kimia Terms & Conditions: 1. Subscription period is Calendar Year (01 Jan 2019 – 31 Dec 2019). 2. Access full text joumal from 1996 to current issue. No Judul p-ISSN e-ISSN Penerbit 1 Accounts of Chemical Research 0001-4842 1520-4898 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 2 ACS Applied Materials & Interfaces 1944-8244 1944-8252 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20036 3 ACS Biomaterials Science & Engineering 2373-9878 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20038 4 ACS Catalysis 2155-5435 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20039 5 ACS Central Science 2374-7951 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20040 6 ACS Chemical Biology 1554-8929 1554-8937 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20041 7 ACS Chemical Neuroscience 1948-7193 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20042 8 ACS Combinatorial Science 2156-8952 2156-8944 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20043 9 ACS Energy Letters - New in 2016 2380-8195 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20044 10 ACS Infectious Diseases 2373-8227 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20045 11 ACS Macro Letters 2161-1653 ACS Publication 1155 Sixteenth Street N.W. Washinton, DC 20046 12 ACS Medicinal Chemistry Letters 1948-5875 ACS Publication 1155 Sixteenth Street N.W.
    [Show full text]
  • Graduate Degrees in Pharmaceutical and Biomedical Sciences
    APPLYING TO PHARMACEUTICAL & BIOMEDICAL SCIENCES: Information and Master of Science Degree: Contact Info Graduate Degrees in • Applicants to the PBS Master’s Program must submit a complete application via the Pharmaceutical and UGA Graduate School’s website: grad.uga. Program information and the edu application can be accessed online at Biomedical Sciences • Additionally, prospective students must rx.uga.edu/departments/academic/ identify a PBS faculty member to serve as a pharmaceutical-biomedical-sciences/ major professor prior to admission. Students should contact faculty members directly Questions also may be directed to inquire and notify the PBS graduate admissions office when a faculty mentor is to the Graduate Coordinator and identified. Graduate Program Specialist at [email protected] Doctor of Philosophy Degree: • Applicant to the PBS PhD program must submit a complete application through the Follow us on social media: UGA Graduate School, via the Integrated Life Sciences program. Instructions for submitting your application can be found at @UGACOPPBS their website: www.ils.uga.edu • The application deadline is December 1, and admission through ILS is only available for @UGA_COP_PBS fall semester admittance. • It is also possible, but less common, for PhD applicants to be admitted directly into the @pharmdawgs program with a pre-selected and confirmed faculty advisor. Direct admit PhD student do not perform rotations. Welcome to the University of Georgia College of • Competitive stipend available. Pharmacy and the Department of Pharmaceutical and Biomedical Sciences! We are delighted with your interest in our graduate programs, which College of Pharmacy include a Master of Sciences (M.S.) as well as a Doctor of Philosophy The University of Georgia is accredited by the Commission on Colleges of the Southern 250 W.
    [Show full text]
  • Gus R. Rosania, Ph.D
    Gus R. Rosania, Ph.D. Current work address: Department of Pharmaceutical Sciences University of Michigan 428 Church Street, Rm.3062 Ann Arbor, MI 48109 e-mail: [email protected] cell:734-358-5661 Current home address: 6052 Quebec Avenue Ann Arbor, MI 48103 Education: 1990-1996 Ph.D. Harvard University, Cambridge MA. (Cell and Developmental Biology; advisor: Dr. Joel A. Swanson 1986-1989 B.S. Biological Sciences, Stanford University, Stanford CA. 1986 High School and Bachillerato diplomas, Colegio Karl C. Parrish, Barranquilla, Colombia 1985 Cornell University Summer Program for High School Students, Ithaca, NY 1984 Mathematical Modeling Training Program, Georgetown University, Washington D.C. Professional Positions 2008- Associate Professor, Dept of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor, MI 2003- Member, University of Michigan Comprehensive Cancer Center 2001-2008 Assistant Professor, Dept. of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor,MI 1999-2001 Scientist, Cellomics, Inc., Pittsburgh, PA. 1997-1999 Research Associate, Howard Hughes Medical Institute, (Dept of Chemistry, University of California, Berkeley, CA; advisor: Dr. Peter G. Schultz) 1990-1996 Research Assistant, Harvard University, Cambridge, MA 1996 Teaching Fellow, Harvard University, Cambridge, MA 1995 Teaching Fellow, Harvard University, Cambridge, MA 1993 Teaching Fellow, Harvard University, Cambridge, MA 1989 Laboratory technician, New York Medical College, Valhalla, NY 1989 Teaching Assistant, Hopkins Marine Station, Pacific Grove, CA Significant
    [Show full text]
  • Faculty Research Expertise of the College of Pharmacy at the University of New Mexico Health Sciences Center Vision, Mission & Values Contents
    Pioneers in Research Faculty research expertise of the College of Pharmacy at The University of New Mexico Health Sciences Center Vision, Mission & Values Contents Vision Letters to the Reader To prepare tomorrow’s leaders through innovative teaching, research and clinical 1 practices that translate scientific discoveries into new treatments and models of From the Dean of the UNM College of Pharmacy care to improve both health and quality of life. 2 From the Associate Dean of Research of the UNM College of Pharmacy Mission Featured Articles The mission of the UNM College of Pharmacy is to develop pharmacists, educators and scientists whose leadership, dedication and innovation improve the 3 Creating a Helping Hand health of our local and global communities. Novel vaccines have potential to treat MRSA infections 5 Nutrients, Medicines and Contaminants Values Metals Are Under the Microscope The UNM College of Pharmacy is committed to the following values: 11 Mining Data • Excellence: continuously striving for the highest quality of performance and outcome. Bigger really is better • Integrity: steadfast adherence to moral and ethical principles. 14 It Starts With A Question • Accountability: being held responsible for one’s actions. And leads to better patient care • Collaboration: work in teams to achieve excellence in education, research/scholarship, 20 Nature or Nurture? patient care and service. How Substance Abuse Affects Development • Continuous Learning: strive to acquire knowledge or skills by study, instruction or experience. 22 Novel Ideas Inventors at the UNM College of Pharmacy • Diversity in People and Thinking: embracing inclusiveness, access and equity for all; recognizing and appreciating the totality of the many ways individuals are similar and different in an atmosphere that promotes and celebrates individual and collective achievements.
    [Show full text]
  • Gus R. Rosania, Ph.D
    Gus R. Rosania, Ph.D. Current work address: Department of Pharmaceutical Sciences University of Michigan 428 Church Street, Rm.3062 Ann Arbor, MI 48109 e-mail: [email protected] cell:734-358-5661 Current home address: 6052 Quebec Avenue Ann Arbor, MI 48103 Education: 1990-1996 Ph.D. Harvard University, Cambridge MA. (Cell and Developmental Biology; advisor: Prof. Joel A. Swanson) 1986-1989 B.S. Biological Sciences, Stanford University, Stanford CA. 1986 High School and Bachillerato diplomas, Colegio Karl C. Parrish, Barranquilla, Colombia 1985 Cornell University Summer Program for High School Students, Ithaca, NY 1984 Mathematical Modeling Training Program, Georgetown University, Washington D.C. Professional Positions 2008- Associate Professor, Dept of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor, MI 2003- Member, University of Michigan Comprehensive Cancer Center 2001-2008 Assistant Professor, Dept. of Pharmaceutical Sciences, Univ of Michigan, Ann Arbor,MI 1999-2001 Scientist, Cellomics, Inc., Pittsburgh, PA. 1997-1999 Research Associate, Howard Hughes Medical Institute, (Dept of Chemistry, University of California, Berkeley, CA; advisor: Dr. Peter G. Schultz) 1990-1996 Research Assistant, Harvard University, Cambridge, MA 1996 Teaching Fellow, Harvard University, Cambridge, MA 1995 Teaching Fellow, Harvard University, Cambridge, MA 1993 Teaching Fellow, Harvard University, Cambridge, MA 1989 Laboratory technician, New York Medical College, Valhalla, NY 1989 Teaching Assistant, Hopkins Marine Station, Pacific Grove, CA Significant
    [Show full text]
  • 2 0 1 6 C a T a L
    2016 CATALOG ACS PUBLICATIONS 2016 CATALOG ABOUTAMERICAN CHEMICAL SOCIETY ACS With more than 158,000 members, the American Chemical Society (ACS) is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization chartered by Congress, ACS is at the forefront of the evolving worldwide chemical enterprise and the premier professional home for chemists, chemical engineers, and related professionals around the globe. 2016 CATALOG Table of Contents>>> VISION About ACS Publications ................................................................................. 3 Unequaled Editorial Excellence and Author Benefits ...........................................................................4 What Fuels ACS Publications’ Growth ......................................................................................................6 Improving people’s lives through the ACS Publications’ Unsurpassed Performance .........................................................................................8 Impact Beyond Impact Factor .................................................................................................................. 10 An Inspiring Online Platform ................................................................................................................... 14 ACS on Campus ........................................................................................................................................... 16 transforming power of chemistry.
    [Show full text]
  • ACS 2015 Journal Summary for Information Professionals.Xlsx
    2015 ACS Journal Information for Librarians First Year of First Year Available Publication or Online with a Print Svc Publication Title Volume 1 Subscription* Website URL Volume Issues Print ISSN Code Web ISSN Accounts of Chemical Research 1968 1996 pubs.acs.org/journal/achre4 47 12 0001‐4842 5500 1520‐4898 ACS Applied Materials & Interfaces 2009 2009 pubs.acs.org/journal/aamick 6 24 1944‐8244 2700 1944‐8252 ACS Biomaterials Science & Engineering ‐ New in 2015 2015 2015 pubs.acs.org/journal/abseba 1 12 Web Only Web Only 2373‐9878 ACS Catalysis 2011 2011 pubs.acs.org/journal/accacs 4 12 Web Only Web Only 2155‐5435 ACS Chemical Biology 2006 2006 pubs.acs.org/journal/acbcct 9 12 1554‐8929 2400 1554‐8937 ACS Chemical Neuroscience 2010 2010 pubs.acs.org/journal/acncdm 5 12 Web Only Web Only 1948‐7193 ACS Combinatorial Science 1999 1999 pubs.acs.org/journal/acsccc 16 12 2156‐8952 3400 2156‐8944 ACS Infectious Diseases ‐ New in 2015 2015 2015 TBA 1 12 Web Only Web Only 2373‐8227 ACS Macro Letters 2012 2012 pubs.acs.org/journal/amlccd 3 12 Web Only Web Only 2161‐1653 ACS Medicinal Chemistry Letters 2010 2010 pubs.acs.org/journal/amclct 5 12 Web Only Web Only 1948‐5875 ACS Nano 2007 2007 pubs.acs.org/journal/ancac3 8 12 1936‐0851 2500 1936‐086X ACS Photonics ‐ New in 2014 2014 2014 pubs.acs.org/journal/apchd5 1 12 Web Only Web Only 2330‐4022 ACS Sustainable Chemistry & Engineering 2013 2013 pubs.acs.org/journal/ascecg 2 12 Web Only Web Only 2168‐0485 ACS Synthetic Biology 2012 2012 pubs.acs.org/journal/asbcd6 3 12 Web Only Web Only 2161‐5063 Analytical
    [Show full text]
  • Journal of Drug Delivery Science and Technology
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Editorial Board p.1 • Guide for Authors p.4 ISSN: 1773-2247 DESCRIPTION . The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed. IMPACT FACTOR . 2020: 3.981 © Clarivate Analytics Journal Citation Reports 2021 EDITORIAL BOARD . Editor-in-Chief Florence Siepmann, University of Lille Faculty of Pharmacy, Lille cedex, France Editors Anna Maria Fadda, University of Cagliari Department of Life Sciences and Environment, Cagliari, Italy Dimitrios Fatouros, Aristotle University of Thessaloniki, Thessaloniki, Greece Kohsaku Kawakami, National Institute for Materials Science, Tsukuba-Shi, Japan Shirui Mao, Shenyang Pharmaceutical University, Shenyang, China Anette Müllertz, University of Copenhagen Faculty of Health and Medical Sciences, København, Denmark Ali Nokhodchi, University of Sussex, Pharmaceutics and Drug Delivery, Brighton, United Kingdom Francisco Javier Otero-Espinar, University of Santiago de Compostela Department of Pharmacology Pharmacy and Pharmaceutical Technology, A Coruña, Spain Michael A. Repka, University of
    [Show full text]
  • MINNECEUTICS Indispensable News
    MINNECEUTICS Indispensable News. University of Minnesota Department of Pharmaceutics Awards & Achievements p. 09-10 Highlighting student and faculty success in 2019-2020. Message from the Directors of Graduate Studies p. 11 How the Pharmaceutics graduate progam is responding to COVID-19. A Year in Photos p. 14 Photos from our lives. Want to be included next year? Send us yours! 2020 Issue 2020 MINNECEUTICS p 2 A Message to Our Friends Dear Friends, Much has been demanded of us during this year of trials. One of those demands was the ability to pivot. Pivoting allows for a change in direction without losing connection to a central point. For us that translates into being flexible, but not breakable; changing our course, but not our core. Our first pivot was this February, when I was elected as Interim Department Head. I took over from Dr. Calvin Sun who graciously served as Temporary Department Head since last November. He led the department well during a time of transition; I want to extend our gratitude to him for it. (Calvin remains as both Associate Department Head and Director of Graduate Studies.) While I am honored to serve as Interim Department Head, we look forward to searching for the next permanent Department Head. We hope to start this search soon, but are currently delayed due to COVID-19. In March, several larger pivots were required. In response to COVID-19, classes moved online, faculty, students and staff settled into work from home, and our labs went into hibernation. Committed to the safety of its members, our department used this hibernation period to carefully devise its Sunrise Plan.
    [Show full text]
  • Research Enterprise a C R M A
    ROLIN A A C P H Y Research Enterprise A C R M A Drug Drug Development Care Delivery Discovery and Evaluation and Practice Discovering the medicines of tomorrow. Maximizing the benefit of medicines today. At the UNC Eshelman School of Pharmacy everything we do begins and ends with a patient in mind. We are focused on accelerating basic and translational science and commercializing bold ideas to find new therapies for the world’s most prevalent illnesses. Research Enterprise Our highly-integrated research enterprise is made up of leading biopharmaceutical research scientists and state-of-the-art facilities that can help you drive the next wave of innovative therapeutics. The Eshelman Institute for Innovation is the engine that drives our faculty discoveries forward. Strategic partnerships are what will “bring them over the finish line. Together, we can Advance Medicine for Life.” Angela Kashuba Dean, UNC Eshelman School of Pharmacy Research Enterprise We are Advancing Medicine for Life through the discovery of medicines of tomorrow, maximizing the benefit of medicines today and training the next generation of pharmacists and pharmaceutical scientists. Our dynamic and highly collaborative patient-focused biopharmaceutical research enterprise spans the entire drug development and delivery cycle. Everything we do begins and ends with a patient in mind. Fast Facts #1 #2 #10 231 48 161 School of in NIH Funding QS Rankings Active issued Formed Invention Pharmacy Pharmacy and patents startups disclosures Pharmacology Health Sciences Campus The UNC Eshelman School of Pharmacy is part of the University of North Carolina at Chapel Hill, a major research university with a large teaching hospital and schools of medicine, public health, nursing, and dentistry as well as the UNC Lineberger Comprehensive Cancer Center.
    [Show full text]